310 results on '"Marks JG Jr"'
Search Results
2. Safety Assessment of Alkyl Amide MIPA Ingredients as Used in Cosmetics.
- Author
-
Akinsulie A, Bergfeld WF, Belsito DV, Klaassen CD, Liebler DC, Marks JG Jr, Peterson LA, Shank RC, Slaga TJ, Snyder PW, Fiume M, and Heldreth B
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of 14 alkyl amide MIPA ingredients as used in cosmetics. All of these ingredients are reported to function in cosmetics as a surfactant - foam booster and/or viscosity increasing agent. The Panel considered the available data, as well as data on read-across sources, and concluded these ingredients are safe in cosmetics in the present practices of use and concentration described in this safety assessment when formulated to be non-irritating., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
3. Safety Assessment of Methylxanthines as Used in Cosmetics.
- Author
-
Cherian PA, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Fiume M, and Heldreth B
- Subjects
- Humans, Animals, Caffeine toxicity, Caffeine pharmacokinetics, Theobromine toxicity, Theophylline toxicity, Theophylline pharmacokinetics, Risk Assessment, Toxicity Tests, Xanthines toxicity, Cosmetics toxicity, Cosmetics chemistry, Consumer Product Safety
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of three methylxanthines, Caffeine, Theobromine, and Theophylline, as used in cosmetics. All of these ingredients are reported to function as skin-conditioning agents in cosmetic products. The Panel reviewed the data relevant to the safety of these ingredients and concluded that Caffeine, Theobromine, and Theophylline are safe in cosmetics in the present practices of use and concentration described in this safety assessment., Competing Interests: Declaration of Conflicting InterestThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
4. Safety Assessment of Polyol Phosphates as Used in Cosmetics.
- Author
-
Johnson W Jr, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Fiume M, and Heldreth B
- Subjects
- Humans, Animals, Phosphates toxicity, Phosphates chemistry, Polymers toxicity, Polymers chemistry, Toxicity Tests, Risk Assessment, Cosmetics toxicity, Cosmetics chemistry, Consumer Product Safety
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) reviewed the safety of 10 polyol phosphates. Some of the possible functions in cosmetics that are reported for this ingredient group are chelating agents, oral care agents, and skin conditioning agents. The Panel reviewed relevant data relating to the safety of these ingredients under the intended conditions of use in cosmetic formulations, and concluded that Sodium Phytate, Phytic Acid, Phytin, and Trisodium Inositol Triphosphate are safe in cosmetics in the present practices of use and concentration described in the safety assessment. The Panel also concluded that the data are insufficient to determine the safety of the following 6 ingredients as used in cosmetics: Disodium Glucose Phosphate, Manganese Fructose Diphosphate, Sodium Mannose Phosphate, Trisodium Fructose Diphosphate, Xylityl Phosphate, and Zinc Fructose Diphosphate., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
5. Safety Assessment of Alkanoyl Lactyl Lactate Salts as Used in Cosmetics.
- Author
-
Johnson W Jr, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Fiume M, and Heldreth B
- Subjects
- Humans, Animals, Risk Assessment, Lactates toxicity, Lactates chemistry, Toxicity Tests, Surface-Active Agents toxicity, Surface-Active Agents chemistry, Surface-Active Agents pharmacokinetics, Cosmetics toxicity, Cosmetics chemistry, Consumer Product Safety
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) reviewed the safety of 10 alkanoyl lactyl lactate salts. These ingredients have the surfactant function in cosmetics in common. The Panel reviewed data relevant to the safety of these ingredients, and concluded that these 10 ingredients are safe in cosmetics in the present practices of use and concentration described in the safety assessment when formulated to be nonirritating and nonsensitizing, which may be based on a quantitative risk assessment (QRA) or other accepted methodologies., Competing Interests: Declaration of Conflicting InterestThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
6. Safety Assessment of Vinylpyrrolidone Polymers as Used in Cosmetics.
- Author
-
Johnson W Jr, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Fiume M, and Heldreth B
- Subjects
- Humans, Animals, Toxicity Tests, Risk Assessment, Cosmetics toxicity, Cosmetics chemistry, Consumer Product Safety, Polymers toxicity, Polymers chemistry, Pyrrolidinones toxicity, Pyrrolidinones chemistry, Pyrrolidinones pharmacokinetics
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) reviewed the safety of 30 vinylpyrrolidone polymers as used in cosmetic products; most of these ingredients have the reported cosmetic function of film former in common. The Panel reviewed data relevant to the safety of these ingredients, and determined that 27 vinylpyrrolidone polymers are safe in cosmetics in the present practices of use and concentration described in the safety assessment. The Panel also concluded that the available data are insufficient to make a determination that 3 vinylpyrrolidone polymers (all urethanes) are safe under the intended conditions of use in cosmetic formulations., Competing Interests: Declaration of Conflicting InterestThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
7. Photopatch testing: Clinical characteristics, test results, and final diagnoses from the North American Contact Dermatitis Group, 2009-2020.
- Author
-
DeLeo VA, Adler BL, Belsito DV, Pratt MD, Sasseville D, Reeder MJ, Warshaw EM, Atwater AR, Taylor JS, Storrs F, Marks JG Jr, DeKoven JG, Silverberg J, Yu J, Botto N, Houle MC, Mowad CM, and Dunnick CA
- Subjects
- Humans, Female, Middle Aged, Adult, Retrospective Studies, Male, Young Adult, North America, Aged, Adolescent, Photosensitivity Disorders diagnosis, Allergens adverse effects, Dermatitis, Allergic Contact diagnosis, Dermatitis, Allergic Contact etiology, Child, Dermatitis, Photoallergic diagnosis, Dermatitis, Photoallergic etiology, Patch Tests methods, Sunscreening Agents adverse effects
- Abstract
Background: Photoallergic contact dermatitis (PACD) is a delayed hypersensitivity reaction to allergens only in the presence of ultraviolet radiation in sunlight. Photopatch testing (PhotoPT) is necessary to confirm the diagnosis of PACD. There are few published studies of PhotoPT in North America., Objective: To summarise the results of patients photopatch tested by members of the North American Contact Dermatitis Group (NACDG), 2009-2020., Methods: Retrospective analysis of patient characteristics and PhotoPT results to 32 allergens on the NACDG Photopatch Test Series., Results: Most of the 454 tested patients were female (70.3%), 21-60 years old (66.7%) and White (66.7%). There were a total of 119 positive photopatch tests. Sunscreen agents comprised 88.2% of those, with benzophenones responsible for over half of them. Final diagnoses included PACD in 17.2%, allergic contact dermatitis (ACD) in 44.5%, polymorphous light eruption (PMLE) in 18.9% and chronic actinic dermatitis (CAD) in 9.0% of patients., Conclusions: In 454 patients with suspected photosensitivity referred for photopatch testing in North America, approximately one-fifth had PACD. Sunscreen agents, especially benzophenones, were the most common photoallergens. Other common diagnoses included ACD, PMLE and CAD. Photopatch testing is an important tool for differentiating these conditions., (© 2024 The Author(s). Contact Dermatitis published by John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
8. Safety Assessment of Hydrogen Peroxide as Used in Cosmetics.
- Author
-
Becker LC, Cherian PA, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Fiume M, and Heldreth B
- Subjects
- Humans, Animals, Risk Assessment, Toxicity Tests, Oxidants toxicity, Hydrogen Peroxide toxicity, Cosmetics toxicity, Cosmetics chemistry, Consumer Product Safety
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of Hydrogen Peroxide for use in cosmetics. This ingredient is reported to function in cosmetics as an antimicrobial agent, cosmetic biocide, oral health care agent, and oxidizing agent. The Panel reviewed the data relevant to the safety of this ingredient and concluded that Hydrogen Peroxide is safe in cosmetics in the present practices of use and concentration described in this safety assessment., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
9. Safety Assessment of Palm-Derived Ingredients as Used in Cosmetics.
- Author
-
Johnson W Jr, Bergfeld WF, Belsito DV, Klaassen CD, Liebler DC, Marks JG Jr, Peterson LA, Shank RC, Slaga TJ, Snyder PW, Fiume M, and Heldreth B
- Subjects
- Humans, Animals, Euterpe chemistry, Euterpe toxicity, Toxicity Tests, Risk Assessment, Cosmetics toxicity, Cosmetics chemistry, Consumer Product Safety
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) reviewed the safety of 8 palm tree ( Euterpe edulis (juçara) and Euterpe oleracea (açaí))-derived ingredients as used in cosmetic products; these ingredients are reported to function mostly as skin conditioning agents. The Panel reviewed relevant data relating to the safety of these ingredients in cosmetic formulations. Industry should continue to use good manufacturing practices to limit impurities. The Panel concluded that palm tree (açaí and juçara)-derived ingredients are safe in cosmetics in the present practices of use and concentration described in this safety assessment., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
10. Safety Assessment of Basic Red 76 as Used in Cosmetics.
- Author
-
Cherian P, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Fiume M, and Heldreth B
- Subjects
- Animals, Humans, Rats, Risk Assessment, Toxicity Tests, Consumer Product Safety, Cosmetics toxicity, Cosmetics chemistry, Hair Dyes toxicity, Hair Dyes chemistry, Hair Dyes pharmacokinetics
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of Basic Red 76, which is reported to function in cosmetics as a hair colorant and hair-conditioning agent. The Panel reviewed the available data to determine the safety of this ingredient. The Panel concluded that Basic Red 76 is safe for use as a hair dye ingredient in the present practices of use and concentration described in the safety assessment., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
11. Safety Assessment of Hydroxyethyl Urea as Used in Cosmetics.
- Author
-
Akinsulie A, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Fiume M, and Heldreth B
- Subjects
- Animals, Humans, Risk Assessment, Toxicity Tests, Consumer Product Safety, Cosmetics toxicity, Cosmetics chemistry, Cosmetics pharmacokinetics, Urea analogs & derivatives, Urea toxicity
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of Hydroxyethyl Urea, which is reported to function as a humectant and a hair and skin conditioning agent. The Panel reviewed the available data to determine the safety of this ingredient. The Panel concluded that Hydroxyethyl Urea is safe in cosmetics in the present practices of use and concentration described in the safety assessment when formulated to be non-irritating., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
12. Safety Assessment of Capryloyl Salicylic Acid as Used in Cosmetics.
- Author
-
Johnson W Jr, Bergfeld WF, Belsito DV, Klaassen CD, Liebler DC, Marks JG Jr, Peterson LA, Shank RC, Slaga TJ, Snyder PW, Fiume M, and Heldreth B
- Subjects
- Animals, Humans, Risk Assessment, Salicylic Acid toxicity, Salicylic Acid pharmacokinetics, Salicylic Acid chemistry, Toxicity Tests, Consumer Product Safety, Cosmetics toxicity, Cosmetics chemistry, Salicylates toxicity, Salicylates pharmacokinetics
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) reassessed the safety of Capryloyl Salicylic Acid in cosmetic products; this ingredient is reported to function as a skin conditioning agent. The Panel reviewed relevant data relating to the safety of this ingredient in cosmetic formulations, and concluded that the available data are insufficient to make a determination that Capryloyl Salicylic Acid is safe under the intended conditions of use in cosmetic formulations., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
13. Safety Assessment of Triphenyl Phosphate as Used in Cosmetics.
- Author
-
Burnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Fiume M, and Heldreth B
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of Triphenyl Phosphate, which is reported to function as a plasticizer in manicuring products. The Panel reviewed the available data to determine the safety of this ingredient. The Panel concluded that Triphenyl Phosphate is safe in cosmetics in the present practices of use and concentration described in this safety assessment., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
14. Safety Assessment of Alkane Diols as Used in Cosmetics.
- Author
-
Scott LN, Fiume M, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, and Heldreth B
- Subjects
- Alcohols, Solvents, Risk Assessment, Consumer Product Safety, Cosmetics toxicity
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of 10 alkane diol ingredients as used in cosmetics. The alkane diols are structurally related to each other as small diols, and most are reported to function in cosmetics as solvents. The Panel reviewed the relevant data for these ingredients, and concluded that seven alkane diols are safe in cosmetics in the present practices of use and concentration described in this safety assessment, but that the available data are insufficient to make a determination of safety for three ingredients, namely 1,4-Butanediol, 2,3-Butanediol, and Octanediol., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: The articles in this supplement were sponsored by the Cosmetic Ingredient Review.
- Published
- 2024
- Full Text
- View/download PDF
15. Safety Assessment of Zinc Salts as Used in Cosmetics.
- Author
-
Scott LN, Fiume M, Zhu J, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, and Heldreth B
- Subjects
- Salts, Consumer Product Safety, Chelating Agents toxicity, Risk Assessment, Cosmetics toxicity, Dermatologic Agents
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of 27 inorganic and organometallic zinc salts as used in cosmetic formulations; these salts are specifically of the
2+ (II) oxidation state cation of zinc. These ingredients included in this report have various reported functions in cosmetics, including hair conditioning agents, skin conditioning agents, cosmetic astringents, cosmetic biocides, preservatives, oral care agents, buffering agents, bulking agents, chelating agents, and viscosity increasing agents. The Panel reviewed the relevant data for these ingredients, and concluded that these 27 ingredients are safe in cosmetics in the present practices of use and concentration described in this safety assessment when formulated to be non-irritating., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: The articles in this supplement were sponsored by the Cosmetic Ingredient Review.- Published
- 2024
- Full Text
- View/download PDF
16. Safety Assessment of Soy-Derived Ingredients as Used in Cosmetics.
- Author
-
Cherian P, Bergfeld WF, Belsito DV, Klaassen CD, Liebler DC, Marks JG Jr, Peterson LA, Shank RC, Slaga TJ, Snyder PW, Fiume M, and Heldreth B
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) reviewed the safety of 28 soy-derived ingredients as used in cosmetic products. These ingredients are reported to primarily function as antioxidants, skin protectants, skin-conditioning agents, and hair-conditioning agents. The Panel considered the available data relating to the safety of these ingredients in cosmetic formulations, and concluded that 24 of the 28 soy-derived ingredients are safe in cosmetics in the present practices of use and concentration described in this safety assessment. The Panel also concluded that the available data are insufficient to make a determination that Glycine Max (Soybean) Callus Culture, Glycine Max (Soybean) Callus Culture Extract, Glycine Max (Soybean) Callus Extract, and Glycine Max (Soybean) Phytoplacenta Conditioned Media are safe under the intended conditions of use in cosmetic formulations., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: The articles in this supplement were sponsored by the Cosmetic Ingredient Review.
- Published
- 2024
- Full Text
- View/download PDF
17. Safety Assessment of Alkyl Sultaines as Used in Cosmetics.
- Author
-
Burnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Fiume M, and Heldreth B
- Subjects
- Skin, Surface-Active Agents, Risk Assessment, Consumer Product Safety, Cosmetics toxicity
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of 13 alkyl sultaines, which are most frequently reported to function in cosmetics as antistatic agents, surfactants, and skin and hair conditioning agents. The Panel reviewed the available data to determine the safety of these ingredients. The Panel noted gaps in the available safety data for some of the alkyl sultaines in this safety assessment; the available data on some of the ingredients are sufficient, however, and can be read across to support the safety of other members of the group. The Panel concluded that these alkyl sultaines are safe in cosmetics in the present practices of use and concentration described in this safety assessment., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: The articles in this supplement were sponsored by the Cosmetic Ingredient Review.
- Published
- 2024
- Full Text
- View/download PDF
18. Safety Assessment of Trialkyl Trimellitates as Used in Cosmetics.
- Author
-
Fiume MM, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Gill LJ, and Heldreth B
- Subjects
- Consumer Product Safety, Esters, Risk Assessment, Cosmetics toxicity, Dermatologic Agents
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of 5 trialkyl trimellitates. These ingredients, which are all structurally related as alkyl esters of trimellitic acid, are reported to function in cosmetics as skin conditioning agents; 2 of the ingredients are also reported to function in cosmetics as plasticizers. The Panel reviewed the available data to determine the safety of these ingredients, and concluded that the trialkyl trimellitates are safe in the current practices of use and concentration when formulated to be non-irritating., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: The articles in this supplement were sponsored by the Cosmetic Ingredient Review.
- Published
- 2024
- Full Text
- View/download PDF
19. Safety Assessment of Butyrospermum parkii (Shea)-Derived Ingredients as Used in Cosmetics.
- Author
-
Burnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Fiume M, and Heldreth B
- Subjects
- Consumer Product Safety, Cosmetics toxicity
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of 13 Butyrospermum parkii (shea)-derived ingredients, which are most frequently reported to function in cosmetics as skin and hair conditioning agents. The Panel reviewed the available data to determine the safety of these ingredients. Because final product formulations may contain multiple botanicals, each containing similar constituents of concern, formulators are advised to be aware of these constituents and to avoid reaching levels that may be hazardous to consumers. Industry should use good manufacturing practices to limit impurities that could be present in botanical ingredients. The Panel concluded that these ingredients are safe in the present practices of use and concentration when formulated to be non-sensitizing., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: The articles in this supplement were sponsored by the Cosmetic Ingredient Review.
- Published
- 2024
- Full Text
- View/download PDF
20. Safety Assessment of Hops as Used in Cosmetics.
- Author
-
Becker L, Boyer I, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Fiume M, and Heldreth B
- Subjects
- Consumer Product Safety, Plant Extracts toxicity, Humulus, Biological Products, Cosmetics toxicity
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of Humulus Lupulus (Hops) Extract (reported functions include antimicrobial agent and hair conditioning agent) and Humulus Lupulus (Hops) Oil (reported function is fragrance). The Panel reviewed the relevant data related to these ingredients. Because final product formulations may contain multiple botanicals, each containing the same constituents of concern, formulators are advised to be aware of these constituents and to avoid reaching levels that may be hazardous to consumers. For these ingredients, the Panel was concerned about the presence of 8-prenylnaringenin, β-myrcene, and quercetin in cosmetics, which could result in estrogenic effects, dermal irritation, and genotoxicity, respectively. Industry should use current good manufacturing practices to limit impurities and constituents of concern. The Panel concluded that Humulus Lupulus (Hops) Extract and Humulus Lupulus (Hops) Oil are safe in cosmetics in the present practices of use and concentration when formulated to be non-sensitizing., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: The articles in this supplement were sponsored by the Cosmetic Ingredient Review.
- Published
- 2024
- Full Text
- View/download PDF
21. Safety Assessment of Adenosine as Used in Cosmetics.
- Author
-
Cherian P, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Fiume M, and Heldreth B
- Subjects
- Consumer Product Safety, Adenosine Triphosphate, Risk Assessment, Adenosine toxicity, Cosmetics toxicity
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of Adenosine, Adenosine Phosphate, Adenosine Triphosphate, Disodium Adenosine Phosphate, and Disodium Adenosine Triphosphate. These ingredients are reported to function in cosmetics as skin-conditioning agents - miscellaneous. The Panel considered the available data and concluded that the five adenosine ingredients reviewed in this report are safe in cosmetics in the present practices of use and concentration described in this safety assessment., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: The articles in this supplement were sponsored by the Cosmetic Ingredient Review.
- Published
- 2024
- Full Text
- View/download PDF
22. Safety Assessment of Polyfluorinated Polymers as Used in Cosmetics.
- Author
-
Johnson W Jr, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Fiume M, and Heldreth B
- Subjects
- Consumer Product Safety, Polytetrafluoroethylene, Risk Assessment, Polymers toxicity, Cosmetics toxicity
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) reviewed the safety of 12 polyfluorinated polymers in cosmetic products; most of these ingredients have the reported function of film former in common. However, PTFE, the only ingredient that is reported as currently used in cosmetics, functions as a bulking agent and slip modifier, but not as a film former. The Panel reviewed data relevant to the safety of these ingredients under the intended conditions of use in cosmetic formulations, and concluded that PTFE and Hexafluoropropylene/Tetrafluoroethylene Copolymer are safe in cosmetics in the present practices of use and concentration described in the safety assessment; the data are insufficient to determine the safety of the 4 fluorinated-side-chain polymers and 6 fluorinated polyethers., Competing Interests: Declaration of conflicting interestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: The articles in this supplement were sponsored by the Cosmetic Ingredient Review.
- Published
- 2023
- Full Text
- View/download PDF
23. Safety Assessment of Polyglyceryl Fatty Acid Esters as Used in Cosmetics.
- Author
-
Fiume MM, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Gill LJ, and Heldreth B
- Subjects
- Fatty Acids toxicity, Esters toxicity, Risk Assessment, Consumer Product Safety, Cosmetics toxicity
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of 274 polyglyceryl fatty acid esters. Each of the esters in this group is a polyether comprising 2 to 20 glyceryl residues, end-capped by esterification with simple carboxylic acids, such as fatty acids. Most of these ingredients are reported to function in cosmetics as skin-conditioning agents and/or surfactants. The Panel reviewed the available data and considered conclusions from their relevant previous reports, and determined that these ingredients are safe in cosmetics in the present practices of use and concentration described in this safety assessment when formulated to be non-irritating.
- Published
- 2023
- Full Text
- View/download PDF
24. Safety Assessment of Centella asiatica -Derived Ingredients as Used in Cosmetics.
- Author
-
Johnson W Jr, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Gill LJ, and Heldreth B
- Subjects
- Consumer Product Safety, Risk Assessment, Plant Extracts toxicity, Centella, Cosmetics toxicity
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of 9 Centella asiatica -derived ingredients, which reportedly function primarily as skin conditioning agents in cosmetic products. The Panel reviewed relevant data relating to the safety of these ingredients. The Panel concluded that Centella Asiatica Extract, Centella Asiatica Callus Culture, Centella Asiatica Flower/Leaf/Stem Extract, Centella Asiatica Leaf Cell Culture Extract, Centella Asiatica Leaf Extract, Centella Asiatica Leaf Water, Centella Asiatica Meristem Cell Culture, Centella Asiatica Meristem Cell Culture Extract, and Centella Asiatica Root Extract are safe in the present practices of use and concentration in cosmetics, as described in this safety assessment, when formulated to be non-sensitizing.
- Published
- 2023
- Full Text
- View/download PDF
25. Safety Assessment of Cocos nucifera (Coconut)-Derived Ingredients as Used in Cosmetics.
- Author
-
Akinsulie A, Burnett C, Bergfeld WF, Belsito DV, Cohen DE, Klaassen CD, Liebler DC, Marks JG Jr, Peterson LA, Shank RC, Slaga TJ, Snyder PW, and Heldreth B
- Subjects
- Consumer Product Safety, Cocos, Cosmetics toxicity
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of 11 Cocos nucifera (coconut)-derived ingredients, most of which are reported to function as skin-conditioning agents in cosmetic products. The Panel reviewed the available data to determine the safety of these ingredients. The Panel concluded that 10 ingredients, derived from coconut flower, fruit, and liquid endosperm, are safe in cosmetics in the present practices of use and concentration described in this safety assessment, and that the available data are insufficient to make a determination of safety for Cocos Nucifera (Coconut) Shell Powder under the intended conditions of use in cosmetic formulations.
- Published
- 2023
- Full Text
- View/download PDF
26. Amended Safety Assessment of Triglycerides as Used in Cosmetics.
- Author
-
Fiume MM, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, and Heldreth B
- Subjects
- Emollients, Risk Assessment, Solvents, Consumer Product Safety, Cosmetics toxicity, Triglycerides toxicity
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of 51 triglycerides; 25 of these ingredients were previously reviewed by the Panel, and 26 are reviewed herein for the first time. The majority of the ingredients named in this assessment have several functions, with most reported to function as skin conditioning agents (occlusive or emollient) and/or viscosity increasing agents in cosmetics; some are also reported to function as a fragrance or solvent. The Panel reviewed relevant new data, including frequency and concentration of use, and considered the data from previous reports. The Panel concluded the 51 triglycerides reviewed in this report are safe in cosmetics in the present practices of use and concentration described in this safety assessment.
- Published
- 2022
- Full Text
- View/download PDF
27. Safety Assessment of Panthenol, Pantothenic Acid, and Derivatives as Used in Cosmetics.
- Author
-
Scott LN, Fiume M, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, and Heldreth B
- Subjects
- Hygroscopic Agents, Pantothenic Acid analogs & derivatives, Pantothenic Acid toxicity, Risk Assessment, Solvents, Consumer Product Safety, Cosmetics toxicity
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of Panthenol, Pantothenic Acid, and 5 derivatives as used in cosmetics. These ingredients named in this report are reported to function in cosmetics as hair conditioning agents, and Panthenol also is reported to function as a skin-conditioning agent-humectant and a solvent. The Panel reviewed relevant data for these ingredients, and concluded that these 7 ingredients are safe in cosmetics in the present practices of use concentration described in this safety assessment.
- Published
- 2022
- Full Text
- View/download PDF
28. Amended Safety Assessment of Malic Acid and Sodium Malate as Used in Cosmetics.
- Author
-
Burnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, and Heldreth B
- Subjects
- Consumer Product Safety, Hygroscopic Agents, Risk Assessment, Sodium, Cosmetics toxicity, Malates toxicity
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) re-reviewed the safety of Malic Acid and Sodium Malate in cosmetics. Malic Acid is reported to function in cosmetics as a fragrance ingredient and a pH adjuster and Sodium Malate functions as a skin-conditioning agent - humectant. The Panel reviewed the available data to determine the safety of these ingredients. The Panel concluded that Malic Acid and Sodium Malate are safe in cosmetics in the present practices of use and concentration described in this safety assessment.
- Published
- 2022
- Full Text
- View/download PDF
29. Prevalence and trend of allergen sensitization in patients with a diagnosis of stasis dermatitis referred for patch testing, North American contact dermatitis group data, 2001-2016.
- Author
-
Silverberg JI, Hou A, Warshaw EM, Maibach HI, Belsito DV, DeKoven JG, Zug KA, Taylor JS, Sasseville D, Fransway AF, DeLeo VA, Pratt MD, Reeder MJ, Atwater AR, Fowler JF Jr, Zirwas MJ, and Marks JG Jr
- Subjects
- Allergens adverse effects, Bacitracin, Benzalkonium Compounds, Formaldehyde, Humans, Methenamine analogs & derivatives, North America epidemiology, Patch Tests, Prevalence, Propylene Glycol, Retrospective Studies, Cosmetics, Dermatitis, Allergic Contact diagnosis, Dermatitis, Allergic Contact epidemiology, Eczema
- Abstract
Background: Few studies explored the relationship between stasis dermatitis (SD) and allergic contact dermatitis (ACD)., Objective: To examine trends, associations, and clinical relevance of ACD in patients referred for patch testing who had a final SD diagnosis., Methods: Retrospective analysis from 2001 to 2016 of 38,723 patients from the North American Contact Dermatitis Group., Results: After patch testing, 303 (0.7%) patients were diagnosed with SD; 46.7% had a concomitant diagnosis of ACD. Patients with vs. without a final SD diagnosis had similar proportions of ≥ 1 positive allergic reaction (59.7% vs. 64.7%; Chi-square, P = 0.0724) but higher odds of allergic reactions to fragrance mix I, bacitracin, quaternium-15, Myroxylon pereirae, benzalkonium chloride, ethyleneurea melamine formaldehyde, diazolidinyl urea, and propylene glycol. The most commonly relevant allergens in patients with final SD diagnosis were fragrance mix I, Myroxylon pereirae, bacitracin, quaternium-15, and formaldehyde. The most common allergen sources were personal care products, topical medications and other health aid products., Conclusion: Nearly half of patients with a final SD diagnosis were also diagnosed with ACD, supporting the role of patch testing in select SD patients., (© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
30. Safety Assessment of Hydroxyethyl-3,4-Methylenedioxyaniline HCl as Used in Cosmetics.
- Author
-
Scott LN, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, and Heldreth B
- Subjects
- Consumer Product Safety, Risk Assessment, Cosmetics toxicity, Hair Dyes
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) reviewed the safety of Hydroxyethyl-3,4-Methylenedioxyaniline HCl, which is reported to function as a hair dye ingredient. The Panel reviewed relevant data provided in this safety assessment, and concluded that Hydroxyethyl-3,4-Methylenedioxyaniline HCl is safe for use as a hair dye ingredient in the present practices of use and concentrations described in this report. The Panel cautions that this ingredient should not be used in cosmetic products in which N -nitroso compounds can be formed.
- Published
- 2022
- Full Text
- View/download PDF
31. Safety Assessment of Bovine Milk Proteins and Protein Derivatives as Used in Cosmetics.
- Author
-
Burnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, and Heldreth B
- Subjects
- Milk Proteins toxicity, Risk Assessment, Skin, Consumer Product Safety, Cosmetics toxicity
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) reviewed the safety of 16 bovine milk proteins and protein-derived ingredients, which function mainly as skin and hair conditioning agents in personal care products. The Panel reviewed relevant data provided in this safety assessment, and concluded that these ingredients are safe in the present practices of use and concentration.
- Published
- 2022
- Full Text
- View/download PDF
32. Safety Assessment of Plant-Derived Proteins and Peptides as Used in Cosmetics.
- Author
-
Burnett CL, Boyer IJ, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, and Heldreth B
- Subjects
- Peptides toxicity, Plant Extracts, Plant Proteins, Risk Assessment, Consumer Product Safety, Cosmetics toxicity
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) reviewed the safety of 19 plant-derived proteins and peptides, which function mainly as skin and/or hair conditioning agents in personal care products. The Panel concluded that 18 plant-derived proteins and peptides are safe as used in the present practices of use and concentration as described in this safety assessment, while the data on Hydrolyzed Maple Sycamore Protein are insufficient to determine safety.
- Published
- 2022
- Full Text
- View/download PDF
33. Safety Assessment of Hydrofluorocarbon 152a as Used in Cosmetics.
- Author
-
Burnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Gill LJ, and Heldreth B
- Subjects
- Risk Assessment, Consumer Product Safety, Cosmetics toxicity
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) reviewed the safety of Hydrofluorocarbon 152a, which functions as a propellant in personal care products. The Panel reviewed relevant data provided in this safety assessment, and concluded that Hydrofluorocarbon 152a is safe in the present practices of use and concentration described in this safety assessment.
- Published
- 2022
- Full Text
- View/download PDF
34. Amended Safety Assessment of Butyl Polyoxyalkylene Ethers as Used in Cosmetics.
- Author
-
Fiume MM, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Gill LJ, and Heldreth B
- Subjects
- Consumer Product Safety, Ethers chemistry, Ethers toxicity, Risk Assessment, Cosmetics chemistry, Cosmetics toxicity, Dermatologic Agents chemistry
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of 46 butyl polyoxyalkylene ethers that share a common structural motif, namely a butyl chain (4 carbon alkyl chain) bound to a polyoxyalkylene (PPG, PEG, or both); 23 of these ethers were previously reviewed by the Panel, and 23 are reviewed herein for the first time. Most of the butyl polyoxyalkylene ethers have several functions in cosmetics, but the most common reported functions include hair conditioning agent and skin conditioning agent, and many reportedly function as solvents. Upon review of new data, including frequency and concentration of use, and data from previous Panel reports and on read-across analogs, the Panel concluded that these ingredients are safe in the present practices of use and concentration in cosmetics when formulated to be non-irritating.
- Published
- 2022
- Full Text
- View/download PDF
35. Safety Assessment of 1-Hydroxyethyl 4,5-Diamino Pyrazole Sulfate as Used in Cosmetics.
- Author
-
Burnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Gill LJ, and Heldreth B
- Subjects
- Consumer Product Safety, Risk Assessment, Sulfates, Cosmetics toxicity, Hair Dyes
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) reviewed the safety of 1-Hydroxyethyl 4,5-Diamino Pyrazole Sulfate, which functions as an oxidative hair dye ingredient. The Panel reviewed relevant data provided in this safety assessment, and concluded that 1-Hydroxyethyl 4,5-Diamino Pyrazole Sulfate is safe in the present practices of use and concentration in oxidative hair dye formulations.
- Published
- 2022
- Full Text
- View/download PDF
36. Photopatch test results of the North American contact dermatitis group, 1999-2009.
- Author
-
DeLeo VA, Adler BL, Warshaw EM, Maibach HI, Belsito DV, Fowler JF Jr, Fransway AF, Marks JG Jr, Mathias CGT, Pratt MD, Rietschel RL, Storrs FJ, Zug KA, and Sasseville D
- Subjects
- Allergens, Humans, North America, Patch Tests methods, Retrospective Studies, Dermatitis, Contact diagnosis, Dermatitis, Contact etiology, Dermatitis, Photoallergic
- Published
- 2022
- Full Text
- View/download PDF
37. Establishing Consensus on the Treatment of Toxicodendron Dermatitis.
- Author
-
Butt M, Marks JG Jr, and Flamm A
- Subjects
- Consensus, Humans, Dermatitis, Allergic Contact, Dermatitis, Toxicodendron, Skin Diseases
- Abstract
Background: Toxicodendron dermatitis (TD) is a common form of allergic contact dermatitis that affects millions of Americans every year. Studies have shown that although there are general recommendations for the treatment of TD, there are no treatment algorithms for clinicians to follow when patients present with TD., Objective: The objective of this study was to achieve consensus on the treatment of TD to create practical guidelines for physicians who treat TD., Methods: Data were collected from March 2020 to April 2021. This study included semistructured focus groups and a Delphi Study with dermatologists to achieve consensus., Results: A total of 51 dermatologists were included in the Delphi. Final agreement with proposed severity criteria ranged from 90.9% to 100.0%. Primary indicators of disease severity were body surface area, presence and severity of pruritus, and anatomic locations of eruptions with 77.4% agreement. Final agreement for the treatment algorithm was over the threshold majority agreement at 67.6%., Conclusions: Literature guiding the treatment of TD is scarce. The use of the Delphi method and focus groups can help expand dermatological resources both within dermatology and to other specialties that may need to treat skin conditions., Competing Interests: This study was supported by the Clinical Research Award from the American Contact Dermatitis Society. M.B. was supported by the Pennsylvania State University Primary Care Research Fellowship, funded by grant T32HP42015 from the Health Resources and Services Administration. J.G.M. is a consultant for Hapten Sciences. The other authors have no funding or conflicts of interest to declare., (Copyright © 2022 American Contact Dermatitis Society. All Rights Reserved.)
- Published
- 2022
- Full Text
- View/download PDF
38. Age-related differences in patch testing results among children: Analysis of North American Contact Dermatitis Group Data, 2001-2018.
- Author
-
Silverberg JI, Hou A, Warshaw EM, DeKoven JG, Maibach HI, Belsito DV, Zug KA, Taylor JS, Sasseville D, Dunnick CA, Houle MC, Atwater AR, Reeder MJ, DeLeo VA, Pratt MD, Fowler JF Jr, Zirwas MJ, and Marks JG Jr
- Subjects
- Adult, Allergens adverse effects, Child, Humans, North America epidemiology, Patch Tests methods, Retrospective Studies, Dermatitis, Allergic Contact diagnosis, Dermatitis, Allergic Contact epidemiology, Dermatitis, Allergic Contact etiology
- Abstract
Background: An updated understanding of allergic contact dermatitis is needed, particularly in children., Objectives: To compare positive and clinically relevant reactions in children versus adults referred for patch testing., Methods: Retrospective analysis of 1871 children and 41,699 adults from the North American Contact Dermatitis Group (NACDG) from 2001-2018., Results: Both final diagnosis of allergic contact dermatitis (55.2% versus 57.3%; chi square, P = .0716) and prevalence of ≥ 1 currently relevant reaction to a NACDG screening allergen (49.2% vs 52.2%; P = .1178) were similar between children and adults. Currently in children, the most common relevant allergens were nickel sulfate (17.3%), hydroperoxides of linalool (7.8%), methylisothiazolinone (7.7%), cobalt chloride (7.0%), and fragrance mix I (4.9%). Approximately a fifth of children had a positive reaction to a non-NACDG allergen., Conclusion: Over half of children referred for patch testing were diagnosed with allergic contact dermatitis. The most common relevant allergens in children were nickel sulfate, cobalt chloride, and hydroperoxides of linalool. Twenty percent of children had at least 1 positive reaction to allergens/substances not on the NACDG screening series, underscoring the need for comprehensive testing., Competing Interests: Conflicts of interest This study was supported by resources and use of facilities at the Minneapolis Veterans Affairs Medical Center. The contents do not represent the views of the US Department of Veterans Affairs or the US Government. Dr Sasseville receives royalties from UpToDate (Wolters Kluwer Health). Dr Taylor owns noncontrolling common stock in Cigna, Merck, Johnson and Johnson, Astra Zeneca, and Opko Health; is a member of the Cosmetic Ingredient Review Steering Committee; and has a nondependent child who is employed by Pfizer. Dr Warshaw has served as a consultant for Wen by Chaz Dean and Noven Pharmaceuticals and is grant funded by Wen by Chaz Dean. Dr Atwater received a Pfizer Independent Grant for Learning & Change and has consulted for Henkel., (Copyright © 2021 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
39. Allergens in patients with a diagnosis of seborrheic dermatitis, North American Contact Dermatitis Group data, 2001-2016.
- Author
-
Silverberg JI, Hou A, Warshaw EM, Maibach HI, Belsito DV, DeKoven JG, Zug KA, Taylor JS, Sasseville D, Fransway AF, DeLeo VA, Pratt MD, Reeder MJ, Atwater AR, Fowler JF Jr, Zirwas MJ, Marks JG Jr, Dunnick CA, and Houle MC
- Subjects
- Allergens adverse effects, Humans, North America, Patch Tests, Retrospective Studies, Dermatitis, Allergic Contact diagnosis, Dermatitis, Allergic Contact epidemiology, Dermatitis, Seborrheic diagnosis, Dermatitis, Seborrheic epidemiology
- Abstract
Competing Interests: Conflicts of interest Dr Sasseville receives royalties from UpToDate (Wolters Kluwer Health). Dr Taylor owns noncontrolling common stock in Cigna, Merck, Johnson & Johnson, AstraZeneca, and Opko Health and is a member of the Cosmetic Ingredient Review Steering Committee, and a nondependent child is employed by Pfizer. Dr Warshaw has served as a consultant for Wen by Chaz Dean and Noven Pharmaceuticals as well as a grant funded by Wen by Chaz Dean. Dr Atwater received a Pfizer Independent Grant for Learning & Change and has consulted for Henkel. Drs Silverberg, Maibach, Belsito, DeKoven, Zug, Fransway, DeLeo, Pratt, Reeder, Fowler, Zirwas, Marks, Dunnick, and Houle and Author Hou have no conflicts of interest to declare.
- Published
- 2022
- Full Text
- View/download PDF
40. Safety Assessment of Citrus Peel-Derived Ingredients as Used in Cosmetics.
- Author
-
Burnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Gill LJ, and Heldreth B
- Subjects
- Animals, Citrus chemistry, Cosmetics adverse effects, Humans, 5-Methoxypsoralen adverse effects, Citrus adverse effects, Consumer Product Safety, Cosmetics standards
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of 47 Citrus peel-derived ingredients, which are most frequently reported to function in cosmetics as skin conditioning agents. The Panel reviewed the available data to determine the safety of these ingredients. Because final product formulations may contain multiple botanical ingredients, each containing similar constituents of concern, formulators are advised to be aware of these constituents and to avoid reaching levels that may be hazardous to consumers. Industry should use good manufacturing practices to limit impurities that could be present in botanical ingredients. The Panel concluded that Citrus peel-derived ingredients are safe in the present practices of use and concentration in both rinse-off and leave-on cosmetic products when formulated to be non-sensitizing and non-irritating, provided that leave-on products do not contain more than 0.0015% (15 ppm) 5-methoxypsoralen (5-MOP).
- Published
- 2021
- Full Text
- View/download PDF
41. Safety Assessment of Citrus Plant- and Seed-Derived Ingredients as Used in Cosmetics.
- Author
-
Burnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Gill LJ, and Heldreth B
- Subjects
- Animals, Citrus chemistry, Cosmetics adverse effects, Humans, Seeds chemistry, 5-Methoxypsoralen adverse effects, Citrus adverse effects, Consumer Product Safety, Cosmetics standards, Seeds adverse effects
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of 30 Citrus plant- and seed-derived ingredients, which are most frequently reported to function in cosmetics as fragrances and/or skin conditioning agents. Because final product formulations may contain multiple botanicals, each containing similar constituents of concern, formulators are advised to be aware of these constituents and to avoid reaching levels that may be hazardous to consumers. With Citrus plant- and seed-derived ingredients, the Panel was concerned about the presence of the hydroperoxides of limonene and linalool in cosmetics. Industry should use good manufacturing practices to limit impurities. The Panel reviewed the available data presented and concluded that 18 of these ingredients are safe in the present practices of use and concentration when formulated to be non-irritating and non-sensitizing. The data for the remaining 12 ingredients are insufficient to determine safety.
- Published
- 2021
- Full Text
- View/download PDF
42. Safety Assessment of Citrus Fruit-Derived Ingredients as Used in Cosmetics.
- Author
-
Burnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Gill LJ, and Heldreth B
- Subjects
- Animals, Citrus chemistry, Cosmetics adverse effects, Humans, 5-Methoxypsoralen adverse effects, Citrus adverse effects, Consumer Product Safety, Cosmetics standards
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of 80 Citrus fruit-derived ingredients, which are most frequently reported to function in cosmetics as fragrances and/or skin-conditioning agents. The Panel reviewed the available data to determine the safety of these ingredients. Because final product formulations may contain multiple botanicals, each containing similar constituents of concern, formulators are advised to be aware of these constituents and to avoid reaching levels that may be hazardous to consumers. Industry should use good manufacturing practices to limit impurities that could be present in botanical ingredients. The Panel concluded that these ingredients are safe for use in both rinse-off and leave-on cosmetic products when formulated to be non-sensitizing and non-irritating, provided that leave-on products do not contain more than 0.0015% (15 ppm) 5-methoxypsoralen (5-MOP).
- Published
- 2021
- Full Text
- View/download PDF
43. Safety Assessment of Citrus Flower- and Leaf-Derived Ingredients as Used in Cosmetics.
- Author
-
Burnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Gill LJ, and Heldreth B
- Subjects
- Animals, Citrus chemistry, Cosmetics adverse effects, Flowers chemistry, Humans, Plant Leaves chemistry, Citrus adverse effects, Consumer Product Safety, Cosmetics standards, Flowers adverse effects, Plant Leaves adverse effects
- Abstract
The Cosmetic Ingredient Review (CIR) Expert Panel (Panel) assessed the safety of 33 Citrus flower- and leaf-derived ingredients, which are most frequently reported to function in cosmetics as fragrances and/or skin-conditioning agents. The Panel reviewed the available data to determine the safety of these ingredients. Because final product formulations may contain multiple botanicals, each containing similar constituents of concern, formulators are advised to be aware of these constituents and to avoid reaching levels that may be hazardous to consumers. With Citrus flower- and leaf-derived ingredients, the Panel was concerned about the presence of the hydroperoxides of limonene and linalool in cosmetics. Industry should use good manufacturing practices to limit impurities that could be present in botanical ingredients. The Panel concluded that these ingredients are safe in the present practices of use and concentration when formulated to be non-irritating and non-sensitizing.
- Published
- 2021
- Full Text
- View/download PDF
44. Amended Safety Assessment of Fatty Acyl Sarcosines and Sarcosinate Salts as Used in Cosmetics.
- Author
-
Fiume MM, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Gill LJ, and Heldreth B
- Subjects
- Animals, Consumer Product Safety, Cosmetics chemistry, Cosmetics pharmacokinetics, Humans, Irritants chemistry, Irritants pharmacokinetics, Nitroso Compounds chemistry, Risk Assessment, Salts, Sarcosine chemistry, Sarcosine pharmacokinetics, Surface-Active Agents chemistry, Surface-Active Agents pharmacokinetics, Cosmetics toxicity, Irritants toxicity, Sarcosine toxicity, Surface-Active Agents toxicity
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of 5 acyl sarcosines and 9 sarcosinate salts as used in cosmetics; all of these ingredients are reported to function in cosmetics as hair conditioning agents and most also can function as surfactants-cleansing agents. The ingredients reviewed in this assessment are composed of an amide comprising a fatty acyl residue and sarcosine and are either free acids or simple salts thereof. The Panel relied on relevant new data, including concentration of use, and considered data from the previous Panel report, such as the reaction of sarcosine with oxidizing materials possibly resulting in nitrosation and the formation of N -nitrososarcosine. The Panel concluded that these ingredients are safe as used in cosmetics when formulated to be non-irritating, but these ingredients should not be used in cosmetic products in which N -nitroso compounds may be formed.
- Published
- 2021
- Full Text
- View/download PDF
45. Prevalence and trend of allergen sensitization in patients referred for patch testing with a final diagnosis of psoriasis: North American Contact Dermatitis Group data, 2001-2016.
- Author
-
Silverberg JI, Hou A, DeKoven JG, Warshaw EM, Maibach HI, Atwater AR, Belsito DV, Zug KA, Taylor JS, Sasseville D, Fransway AF, DeLeo VA, Pratt MD, Reeder MJ, Fowler JF Jr, Zirwas MJ, Marks JG Jr, Dunnick CA, and Houle MC
- Subjects
- Adolescent, Adult, Comorbidity, Dermatitis, Allergic Contact complications, Female, Humans, Male, North America epidemiology, Patch Tests, Prevalence, Psoriasis complications, Retrospective Studies, Young Adult, Dermatitis, Allergic Contact diagnosis, Dermatitis, Allergic Contact epidemiology, Psoriasis diagnosis, Psoriasis epidemiology
- Abstract
Background: Little is known about the relationship between psoriasis and allergic contact dermatitis (ACD)., Objective: To examine the associations with ACD, related clinical characteristics, and common positive and clinically relevant allergens of patients with a final diagnosis of psoriasis who were referred for patch testing., Methods: Retrospective analysis of 38 723 patients from the North American Contact Dermatitis Group., Results: Patients with a final diagnosis of psoriasis had lower proportions of ACD than those without psoriasis (32.7% vs 57.8%). In multivariable logistic regression models, psoriasis was inversely associated with female sex, Black or Asian race, and history of atopic dermatitis and hay fever. Patients with a final diagnosis of psoriasis were less likely to have one or more positive allergic patch-test reactions or to have a current clinically relevant patch-test reaction to the majority of the most commonly positive and/or relevant allergens. The most clinically relevant allergens included nickel sulfate, methylisothiazolinone, and fragrance mix I., Conclusion: Approximately one-third of patients who were referred for patch testing with a final diagnosis of psoriasis were also diagnosed with ACD. In select patients with suspected psoriasis who also have a clinical presentation suggestive of ACD, patch testing may be helpful., (© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2021
- Full Text
- View/download PDF
46. Safety Assessment of Saccharide Esters as Used in Cosmetics.
- Author
-
Scott LN, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Gill LJ, and Heldreth B
- Subjects
- Animals, Consumer Product Safety, Cosmetics chemistry, Cosmetics pharmacokinetics, Esters chemistry, Esters pharmacokinetics, Humans, Polysaccharides chemistry, Polysaccharides pharmacokinetics, Risk Assessment, Cosmetics toxicity, Esters toxicity, Polysaccharides toxicity
- Abstract
This is a safety assessment of 40 saccharide ester ingredients as used in cosmetics. The saccharide esters are reported to function in cosmetics as emollients, skin-conditioning agents, fragrance ingredients, and emulsion stabilizers. The Expert Panel for Cosmetic Ingredient Safety (Panel) reviewed the relevant data for these ingredients. The Panel concluded that the saccharide esters are safe in cosmetics in the present practices of use and concentrations described in this safety assessment.
- Published
- 2021
- Full Text
- View/download PDF
47. Safety Assessment of Keratin and Keratin-Derived Ingredients as Used in Cosmetics.
- Author
-
Burnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Gill LJ, and Heldreth B
- Subjects
- Animals, Consumer Product Safety, Cosmetics chemistry, Cosmetics pharmacokinetics, Humans, Keratins chemistry, Keratins pharmacokinetics, Risk Assessment, Cosmetics toxicity, Keratins toxicity
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) reviewed the safety of 8 keratin-derived ingredients, which function mainly as skin and hair conditioning agents in personal care products. The Panel reviewed relevant data provided in this safety assessment and concluded that the 8 keratin-derived ingredients are safe in the present practices of use and concentration described in this safety assessment.
- Published
- 2021
- Full Text
- View/download PDF
48. Safety Assessment of Inorganic Hydroxides as Used in Cosmetics.
- Author
-
Burnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Gill LJ, and Heldreth B
- Subjects
- Animals, Consumer Product Safety, Cosmetics chemistry, Cosmetics pharmacokinetics, Humans, Hydroxides chemistry, Hydroxides pharmacokinetics, Irritants chemistry, Irritants pharmacokinetics, Risk Assessment, Cosmetics toxicity, Hydroxides toxicity, Irritants toxicity
- Abstract
The Expert Panel for Cosmetic Ingredient Safety (Panel) reviewed the safety of inorganic hydroxides, which function in cosmetics primarily as pH adjusters. Representatives from the cosmetic industry have indicated these ingredients are used in depilating and hair waving/straightening formulations to raise pH values. The Panel considered relevant data related to these ingredients. The Panel concluded that these inorganic hydroxides are safe in hair straighteners and depilatories under conditions of recommended use; users should minimize skin contact. These ingredients are safe for all other present practices of use and concentration described in this safety assessment when formulated to be nonirritating.
- Published
- 2021
- Full Text
- View/download PDF
49. Inter-rater variability in patch test readings and final interpretation using store-forward teledermatology.
- Author
-
Goodier MC, DeKoven JG, Taylor JS, Sasseville D, Fowler JF Jr, Fransway AF, DeLeo VA, Marks JG Jr, Zug KA, Hylwa SA, and Warshaw EM
- Subjects
- Allergens administration & dosage, Clinical Competence, Dermatologists psychology, Female, Humans, Male, Middle Aged, Office Visits, Photography standards, Self Concept, Dermatitis, Allergic Contact diagnosis, Dermatitis, Irritant diagnosis, Observer Variation, Patch Tests methods, Patch Tests standards, Remote Consultation
- Abstract
Background: Data regarding teledermatology for patch testing are limited., Objectives: Compare patch test readings and final interpretation by two in-person dermatologists (IPDs) with eight teledermatologists (TDs)., Methods: Patch tested patients had photographs taken of 70 screening series of allergens at 48 hours and second readings. Eight TDs reviewed photos and graded reactions (negative, irritant, doubtful, +, ++, +++) at 48 hours and second readings; in addition, they coded a final interpretation (allergic, indeterminant, irritant, negative) for each reaction. TDs rated overall image quality and confidence level for each patient and patch test reaction, respectively. Percentage of TD-IPD agreement based on clinical significance (success, indeterminate, and failure) was calculated. Primary outcome was agreement at the second reading., Results: Data were available for 99, 101, and 66 participants at 48 hours, second reading, and final interpretation, respectively. Pooled failure (+/++/+++ vs negative) at second reading was 13.6% (range 7.9%-20.4%). Pooled failure at 48 hours and final interpretation was 5.4% (range 2.9%-6.8%) and 24.6% (range 10.2%-36.8%), respectively. Confidence in readings was statistically correlated with quality of images and disagreement., Conclusion: For patch testing, teledermatology has significant limitations including clinically significant pooled failure percentages of 13.6% for second readings and 24.6% for final interpretation., (© 2021 John Wiley & Sons A/S . Published by John Wiley & Sons Ltd.)
- Published
- 2021
- Full Text
- View/download PDF
50. Hand eczema in children referred for patch testing: North American Contact Dermatitis Group Data, 2000-2016.
- Author
-
Silverberg JI, Warshaw EM, Maibach HI, DeKoven JG, Taylor JS, Atwater AR, Sasseville D, Zug KA, Reeder MJ, Fowler JF Jr, Pratt MD, Fransway AF, Zirwas MJ, Belsito DV, Marks JG Jr, and DeLeo VA
- Subjects
- Adolescent, Allergens adverse effects, Child, Humans, North America epidemiology, Patch Tests, Retrospective Studies, Dermatitis, Allergic Contact diagnosis, Dermatitis, Allergic Contact epidemiology, Dermatitis, Allergic Contact etiology, Eczema chemically induced, Eczema diagnosis, Eczema epidemiology
- Abstract
Background: Little is known about the aetiologies and relevant allergens in paediatric patients with hand eczema (HE)., Objectives: To characterize the aetiologies and determine the proportion of positive and currently relevant allergens in children/adolescents (age < 18 years) with HE referred for patch testing., Methods: A retrospective analysis (2000-2016) of North American Contact Dermatitis Group data was performed., Results: Of 1634 paediatric patients, 237 (14·5%) had involvement of the hands. Final physician diagnoses included allergic contact dermatitis (49·4%), atopic dermatitis (37·1%) and irritant contact dermatitis (16·9%). In multivariable logistic regression models, employment was the only association with increased odds of any HE or primary HE. Children with HE vs. those without HE had similar proportions of positive patch tests (56·1% vs. 61·7%; χ
2 -test, P = 0·11). The five most common currently relevant allergens were nickel, methylisothiazolinone, propylene glycol, decyl glucoside and lanolin. In multivariable logistic regression models of the top 20 relevant allergens, HE was associated with significantly higher odds of currently relevant reactions to lanolin, quaternium-15, Compositae mix, thiuram mix, 2-mercaptobenzathiazole and colophony. The allergens with the highest mean significance-prevalence index number were methylisothiazolinone, carba mix, thiuram mix, nickel and methylchloroisothiazolinone/methylisothiazolinone., Conclusions: Children with HE who were referred for patch testing had a high proportion of positive patch tests, which was similar to the proportion found in children without HE. Children with HE had a distinct and fairly narrow profile of currently relevant allergens., (© 2021 British Association of Dermatologists.)- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.